← ANALYST RATINGS · TIPRANKS
Veracyte (VCYT): analyst forecast and price target
Analyst consensus
Moderate Buy6 Buy1 Hold1 Sell
Ratings of 8 analysts in the last 3 months · top analysts only12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $57.83, the highest $69.00, the lowest $44.00. The average is +34.1% from the last price of $43.12.
Analyst ratings 13
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $50.00 → $49.00−2.0% | Buy | +13.6% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $50.00 → $49.00−2.0% | Buy | +13.6% | Upgrade | 16.10.26on TipRanks 08:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $50.00 → $49.00−2.0% | Hold | +13.6% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $49.00 → $48.00−2.0% | Hold | +11.3% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $51.00 → $50.00−2.0% | Buy | +16.0% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $51.00 → $50.00−2.0% | Buy | +16.0% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $54.00 | Buy | +25.2% | Reiterated | 17.09.26on TipRanks 07:35 | +4.2%next day −2.0% · 5 days +18.8% | ↗ |
| William Bonello★★★★★★★★★★#152 · hits 66% · avg +35.0% | Craig-Hallum | — | Buy | — | Reiterated | 15.09.26on TipRanks Sep 16 08:50 | −2.1%next day −3.6% · 5 days +5.7% | ↗ |
| Matt Larew★★★★★★★★★★#816 · hits 63% · avg +19.3% | William Blair | — | Buy | — | Reiterated | 15.09.26on TipRanks 12:08 | −2.1%next day −3.6% · 5 days +5.7% | ↗ |
| Keith Hinton★★★★★★★★★★#7123 · hits 80% · avg +7.0% | Freedom Capital Markets | $66.00 | Buy | +53.1% | Reiterated | 15.09.26on TipRanks 06:30 | −2.1%next day −3.6% · 5 days +5.7% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $69.00 | Buy | +60.0% | Reiterated | 15.09.26on TipRanks 05:35 | −2.1%next day −3.6% · 5 days +5.7% | ↗ |
| Doug Schenkel★★★★★★★★★★#216 · hits 65% · avg +26.2% | Wolfe Research | $52.00 → $65.00+25.0% | Buy | +50.7% | Reiterated | 09.09.26on TipRanks 07:35 | +3.8%next day −3.6% · 5 days −11.1% | ↗ |
| Kallum Titchmarsh★★★★★★★★★★#2647 · hits 58% · avg +9.6% | Morgan Stanley | $47.00 → $44.00−6.4% | Sell | +2.0% | Assigned | 04.08.26on TipRanks 08:17 | +1.7%next day −0.4% · 5 days +0.1% | ↗ |
| Mason Carrico★★★★★★★★★★#10833 · hits 38% · avg −4.7% | Stephens | $55.00 | Buy | +27.6% | Reiterated | 04.08.26on TipRanks 07:56 | +1.7%next day −0.4% · 5 days +0.1% | ↗ |
| Kyle Mikson CFA★★★★★★★★★★#2814 · hits 38% · avg +5.9% | Canaccord Genuity | $60.00 → $50.00−16.7% | Hold | +16.0% | Reiterated | 03.08.26on TipRanks 07:26 | −4.6%next day +1.7% · 5 days +1.1% | ↗ |
| Subbu Nambi★★★★★★★★★★#281 · hits 72% · avg +34.4% | Guggenheim | $65.00 | Buy | +50.7% | Reiterated | 31.07.26on TipRanks Aug 3 09:50 | −23.2%next day −4.6% · 5 days −1.6% | ↗ |
| Tycho Peterson★★★★★★★★★★#1097 · hits 57% · avg +9.8% | Jefferies | $70.00 | Buy | +62.3% | Reiterated | 08.07.26on TipRanks Jul 9 02:50 | +0.2%next day +4.8% · 5 days +4.8% | ↗ |
| Paige Chamberlain★★★★★★★★★★#7338 · hits 100% · avg +13.9% | Wolfe Research | $50.00 → $55.00+10.0% | Buy | +27.6% | Assigned | 01.06.26on TipRanks Jun 2 07:15 | +3.7%next day −0.9% · 5 days +0.7% | ↗ |
| Lu Li★★★★★★★★★★#5185 · hits 80% · avg +11.8% | UBS | $48.00 → $52.00+8.3% | Buy | +20.6% | Reiterated | 06.05.26on TipRanks May 9 10:10 | +23.5%next day −0.7% · 5 days −8.3% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Veracyte
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $59.78 at a price of $46.04 (+29.8%); now: $58.50 at $43.12 (+35.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 9 | 10 | 14 | 10 | 12 | 6 |
| Hold | 3 | 4 | 4 | 3 | 2 | 1 |
| Sell | 2 | 1 | 2 | 2 | 2 | 1 |
Earnings and sales forecast
Next report: 04.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.41 (from $0.35 to $0.45). Last quarter: $0.54.
Sales
Next quarter’s sales estimate — $147M (from $145M to $149M). Last quarter: $150M.
Best top-analyst consensus in the sector · Healthcare
About Veracyte
- CEO: Marc Stapley
- Employees: 755
- 6000 Shoreline Court, South San Francisco, CA, 94080, US
- www.veracyte.com
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Data from the stock’s TipRanks forecast page, read 1 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗